This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vandenberg, L. N. Articles by Soto, A. M. Search for Related Content PubMed PubMed Citation Articles by Vandenberg, L. N. Articles by Soto, A. M.

Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption

Tufts University School of Medicine, Department of Anatomy and Cellular Biology, Boston, Massachusetts 02111

Correspondence: Address correspondence and requests for reprints to: Ana M. Soto, Tufts University School of Medicine, Department of Anatomy and Cellular Biology, 136 Harrison Avenue, Boston, Massachusetts 02111. E-mail: ana.soto{at}tufts.edu

In 1991, a group of 21 scientists gathered at the Wingspread Conference Center to discuss evidence of developmental alterations observed in wildlife populations after chemical exposures. There, the term "endocrine disruptor" was agreed upon to describe a class of chemicals including those that act as agonists and antagonists of the estrogen receptors (ERs), androgen receptor, thyroid hormone receptor, and others. This definition has since evolved, and the field has grown to encompass hundreds of chemicals. Despite significant advances in the study of endocrine disruptors, several controversies have sprung up and continue, including the debate over the existence of nonmonotonic dose response curves, the mechanisms of low-dose effects, and the importance of considering critical periods of exposure in experimental design. One chemical found ubiquitously in our environment, bisphenol-A (BPA), has received a tremendous amount of attention from research scientists, government panels, and the popular press. In this review, we have covered the above-mentioned controversies plus six additional issues that have divided scientists in the field of BPA research, namely: 1) mechanisms of BPA action; 2) levels of human exposure; 3) routes of human exposure; 4) pharmacokinetic models of BPA metabolism; 5) effects of BPA on exposed animals; and 6) links between BPA and cancer. Understanding these topics is essential for educating the public and medical professionals about potential risks associated with developmental exposure to BPA and other endocrine disruptors, the design of rigorously researched programs using both epidemiological and animal studies, and ultimately the development of a sound public health policy.

This article has been cited by other articles:

				S. A. Vogel The Politics of Plastics: The Making and Unmaking of Bisphenol A "Safety" Am J Public Health, November 1, 2009; 99(S3): S559 - S566. [Abstract] [Full Text] [PDF]

				P. A. Hunt, M. Susiarjo, C. Rubio, and T. J. Hassold The Bisphenol A Experience: A Primer for the Analysis of Environmental Effects on Mammalian Reproduction Biol Reprod, November 1, 2009; 81(5): 807 - 813. [Abstract] [Full Text] [PDF]

				H. B. Adewale, W. N. Jefferson, R. R. Newbold, and H. B. Patisaul Neonatal Bisphenol-A Exposure Alters Rat Reproductive Development and Ovarian Morphology Without Impairing Activation of Gonadotropin-Releasing Hormone Neurons Biol Reprod, October 1, 2009; 81(4): 690 - 699. [Abstract] [Full Text] [PDF]